ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing

Advanced therapy medicinal products (ATMP) are medicines for human use that are based on genes, cells or tissues. Over the past years, an increasing number of ATMP entered the market for treatment of cancer, genetic disorders, skeletal defects and metabolic diseases. However, the ATMP production met...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, D.N., Chrobok, M., Ahlén, G., Blomberg, P., Sällberg, M., Pasetto, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650027/
https://www.ncbi.nlm.nih.gov/pubmed/36389443
http://dx.doi.org/10.1016/j.iotech.2022.100099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650027/
https://www.ncbi.nlm.nih.gov/pubmed/36389443
http://dx.doi.org/10.1016/j.iotech.2022.100099

Ejemplares similares